Compare with Lupin - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES LUPIN ZIM LABORATORIES/
LUPIN
 
P/E (TTM) x 38.1 -19.2 - View Chart
P/BV x 2.1 2.1 100.8% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 ZIM LABORATORIES   LUPIN
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
LUPIN
Mar-21
ZIM LABORATORIES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1311,122 11.7%   
Low Rs53576 9.2%   
Sales per share (Unadj.) Rs189.2334.2 56.6%  
Earnings per share (Unadj.) Rs4.527.0 16.7%  
Cash flow per share (Unadj.) Rs14.246.6 30.5%  
Dividends per share (Unadj.) Rs06.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs99.0300.1 33.0%  
Shares outstanding (eoy) m16.24453.68 3.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.52.5 19.2%   
Avg P/E ratio x20.531.4 65.2%  
P/CF ratio (eoy) x6.518.2 35.6%  
Price / Book Value ratio x0.92.8 32.9%  
Dividend payout %024.0 0.0%   
Avg Mkt Cap Rs m1,497385,072 0.4%   
No. of employees `000NANA-   
Total wages/salary Rs m35828,259 1.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,073151,630 2.0%  
Other income Rs m231,363 1.7%   
Total revenues Rs m3,096152,993 2.0%   
Gross profit Rs m34625,669 1.3%  
Depreciation Rs m1588,874 1.8%   
Interest Rs m1091,406 7.7%   
Profit before tax Rs m10216,751 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m294,485 0.6%   
Profit after tax Rs m7312,266 0.6%  
Gross profit margin %11.316.9 66.5%  
Effective tax rate %28.526.8 106.4%   
Net profit margin %2.48.1 29.4%  
BALANCE SHEET DATA
Current assets Rs m1,918139,864 1.4%   
Current liabilities Rs m1,42084,361 1.7%   
Net working cap to sales %16.236.6 44.2%  
Current ratio x1.41.7 81.4%  
Inventory Days Days1669 22.7%  
Debtors Days Days858108 796.9%  
Net fixed assets Rs m1,30494,439 1.4%   
Share capital Rs m162907 17.9%   
"Free" reserves Rs m1,445135,229 1.1%   
Net worth Rs m1,608136,136 1.2%   
Long term debt Rs m218161 135.4%   
Total assets Rs m3,222234,302 1.4%  
Interest coverage x1.912.9 15.0%   
Debt to equity ratio x0.10 11,468.1%  
Sales to assets ratio x1.00.6 147.4%   
Return on assets %5.75.8 96.9%  
Return on equity %4.69.0 50.5%  
Return on capital %11.613.3 86.9%  
Exports to sales %67.40-   
Imports to sales %4.10-   
Exports (fob) Rs m2,072NA-   
Imports (cif) Rs m127NA-   
Fx inflow Rs m2,14051,027 4.2%   
Fx outflow Rs m12721,081 0.6%   
Net fx Rs m2,01229,946 6.7%   
CASH FLOW
From Operations Rs m31918,218 1.7%  
From Investments Rs m-59-12,396 0.5%  
From Financial Activity Rs m-260-18,853 1.4%  
Net Cashflow Rs m-1-13,031 0.0%  

Share Holding

Indian Promoters % 33.3 46.5 71.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.0 41.9 -  
FIIs % 0.0 14.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 53.2 125.4%  
Shareholders   3,561 378,547 0.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Related Views on News

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


May 20, 2022 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 5-YR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS